{"id":"https://openalex.org/W2132625873","doi":"https://doi.org/10.1038/bjc.1998.500","title":"A randomized phase II trial of interleukin 2 and interleukin 2-interferon alpha in advanced renal cancer","display_name":"A randomized phase II trial of interleukin 2 and interleukin 2-interferon alpha in advanced renal cancer","alternate_titles":[],"publication_year":1998,"publication_date":"1998-08-01","ids":{"openalex":"https://openalex.org/W2132625873","doi":"https://doi.org/10.1038/bjc.1998.500","mag":"2132625873","pmid":"https://pubmed.ncbi.nlm.nih.gov/9703284","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2063040"},"language":"en","primary_location":{"id":"doi:10.1038/bjc.1998.500","doi":"https://doi.org/10.1038/bjc.1998.500","is_oa":true,"landing_page_url":"https://doi.org/10.1038/bjc.1998.500","pdf_url":"https://www.nature.com/articles/bjc1998500.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2132625873"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.nature.com/articles/bjc1998500.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023247842","display_name":"Gordon C. Jayson","orcid":"https://orcid.org/0000-0002-8515-8944","observed_orcids":["https://orcid.org/0000-0002-8515-8944"]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"GC Jayson","raw_affiliation_strings":["CRC Department of Medical Oncology, Christie Hospital, Withington, Manchester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CRC Department of Medical Oncology, Christie Hospital, Withington, Manchester, UK","institution_ids":["https://openalex.org/I4210131968"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051430596","display_name":"Mark Ross Middleton","orcid":"https://orcid.org/0000-0003-0167-1685","observed_orcids":["https://orcid.org/0000-0003-0167-1685"]},"institutions":[{"id":"https://openalex.org/I2800824388","display_name":"Withington Community Hospital","ror":"https://ror.org/0401p8597","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800824388","https://openalex.org/I4210092852"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M Middleton","raw_affiliation_strings":["CRC Department of Medical Oncology. Chnstie Hospital. Wthington. Manchester M20 4BX. UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CRC Department of Medical Oncology. Chnstie Hospital. Wthington. Manchester M20 4BX. UK","institution_ids":["https://openalex.org/I2800824388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023781617","display_name":"Siow Ming Lee","orcid":"https://orcid.org/0000-0002-1741-6235","observed_orcids":["https://orcid.org/0000-0002-1741-6235"]},"institutions":[{"id":"https://openalex.org/I2800824388","display_name":"Withington Community Hospital","ror":"https://ror.org/0401p8597","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800824388","https://openalex.org/I4210092852"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"SM Lee","raw_affiliation_strings":["CRC Department of Medical Oncology. Chnstie Hospital. Wthington. Manchester M20 4BX. UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CRC Department of Medical Oncology. Chnstie Hospital. Wthington. Manchester M20 4BX. UK","institution_ids":["https://openalex.org/I2800824388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025124724","display_name":"Linda Ashcroft","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800824388","display_name":"Withington Community Hospital","ror":"https://ror.org/0401p8597","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800824388","https://openalex.org/I4210092852"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"L Ashcroft","raw_affiliation_strings":["CRC Department of Medical Oncology. Chnstie Hospital. Wthington. Manchester M20 4BX. UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CRC Department of Medical Oncology. Chnstie Hospital. Wthington. Manchester M20 4BX. UK","institution_ids":["https://openalex.org/I2800824388"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110052001","display_name":"N. Thatcher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800824388","display_name":"Withington Community Hospital","ror":"https://ror.org/0401p8597","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800824388","https://openalex.org/I4210092852"]},{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"N Thatcher","raw_affiliation_strings":["CRC Department of Medical Oncology . Chnstie Hospital. Wthington . Manchester M20 4BX . UK","CRC Department of Medical Oncology, Christie Hospital, Manchester, Withington, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CRC Department of Medical Oncology . Chnstie Hospital. Wthington . Manchester M20 4BX . UK","institution_ids":["https://openalex.org/I2800824388"]},{"raw_affiliation_string":"CRC Department of Medical Oncology, Christie Hospital, Manchester, Withington, UK","institution_ids":["https://openalex.org/I4210131968"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5110052001"],"corresponding_institution_ids":["https://openalex.org/I2800824388","https://openalex.org/I4210131968"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":null,"fwci":1.5643,"has_fulltext":true,"cited_by_count":35,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.83180078,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":93},"biblio":{"volume":"78","issue":"3","first_page":"366","last_page":"369"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.9300000071525574},{"id":"https://openalex.org/keywords/interferon-alpha","display_name":"interferon-alpha","score":0.8119999766349792},{"id":"https://openalex.org/keywords/renal-cell-carcinoma","display_name":"renal cell carcinoma","score":0.7580000162124634},{"id":"https://openalex.org/keywords/metastatic-renal-cell-carcinoma","display_name":"metastatic renal cell carcinoma","score":0.8420000076293945},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.7760000228881836},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.6769999861717224},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.8610000014305115},{"id":"https://openalex.org/keywords/nephrectomy","display_name":"nephrectomy","score":0.6620000004768372},{"id":"https://openalex.org/keywords/subcutaneous-administration","display_name":"subcutaneous administration","score":0.5519999861717224}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8458130359649658},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6696053743362427},{"id":"https://openalex.org/C2909179924","wikidata":"https://www.wikidata.org/wiki/Q6046488","display_name":"Alpha interferon","level":3,"score":0.6355591416358948},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.6320253610610962},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.55821692943573},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.5523906946182251},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5341068506240845},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5334064960479736},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5182990431785583},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5119668245315552},{"id":"https://openalex.org/C2780227381","wikidata":"https://www.wikidata.org/wiki/Q1357376","display_name":"Nephrectomy","level":3,"score":0.48518186807632446},{"id":"https://openalex.org/C2781228144","wikidata":"https://www.wikidata.org/wiki/Q6046441","display_name":"Interferon alfa","level":4,"score":0.46127912402153015},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.313399076461792},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.20729950070381165},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.18330717086791992},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.17645999789237976},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.14906567335128784}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005221","descriptor_name":"Fatigue","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014839","descriptor_name":"Vomiting","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false}],"locations_count":7,"locations":[{"id":"doi:10.1038/bjc.1998.500","doi":"https://doi.org/10.1038/bjc.1998.500","is_oa":true,"landing_page_url":"https://doi.org/10.1038/bjc.1998.500","pdf_url":"https://www.nature.com/articles/bjc1998500.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2063040","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2063040/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Cancer","raw_type":"Text"},{"id":"pmid:9703284","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9703284","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of cancer","raw_type":"Clinical Trial"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/1c0783dc-154e-4ba0-8095-ba7a8a91feca","doi":null,"is_oa":false,"landing_page_url":"https://research.manchester.ac.uk/en/publications/1c0783dc-154e-4ba0-8095-ba7a8a91feca","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Jayson, G C, Middleton, M, Lee, S M, Ashcroft, L & Thatcher, N 1998, 'A randomized phase II trial of interleukin 2 and interleukin 2-interferon alpha in advanced renal cancer', British Journal of Cancer, vol. 78, no. 3, pp. 366-369.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/79793669-a882-4b45-9952-a7b7bb48f4cb","doi":null,"is_oa":false,"landing_page_url":"https://research.manchester.ac.uk/en/publications/79793669-a882-4b45-9952-a7b7bb48f4cb","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Jayson, GC, Middleton, M, Lee, SM, Ashcroft, L & Thatcher, N 1998, 'A randomised phase II trial of Interleukin 2 and Interleukin 2/ interferon \uf061 in advanced renal cancer', British J. Cancer.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:158498","doi":null,"is_oa":false,"landing_page_url":"http://discovery.ucl.ac.uk/158498/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"BRITISH JOURNAL OF CANCER , 78 (3) pp. 366-369. (1998)","raw_type":"Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.284.185","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.284.185","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/0c/85/Br_J_Cancer_1998_Aug_78(3)_366-369.tar.gz","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1038/bjc.1998.500","doi":"https://doi.org/10.1038/bjc.1998.500","is_oa":true,"landing_page_url":"https://doi.org/10.1038/bjc.1998.500","pdf_url":"https://www.nature.com/articles/bjc1998500.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2132625873.pdf","grobid_xml":"https://content.openalex.org/works/W2132625873.grobid-xml"},"referenced_works_count":19,"referenced_works":["https://openalex.org/W1985739508","https://openalex.org/W2024186028","https://openalex.org/W2042178436","https://openalex.org/W2043704799","https://openalex.org/W2063454635","https://openalex.org/W2072778837","https://openalex.org/W2088391922","https://openalex.org/W2101685698","https://openalex.org/W2133988080","https://openalex.org/W2141608710","https://openalex.org/W2155221651","https://openalex.org/W2173123780","https://openalex.org/W2288411995","https://openalex.org/W2333952993","https://openalex.org/W2340256585","https://openalex.org/W2421456797","https://openalex.org/W2465056471","https://openalex.org/W3022038294","https://openalex.org/W4252547201"],"related_works":["https://openalex.org/W2294866259","https://openalex.org/W2133988080","https://openalex.org/W37165807","https://openalex.org/W1992756775","https://openalex.org/W2000500113","https://openalex.org/W1978241641","https://openalex.org/W1904017285","https://openalex.org/W2034642961","https://openalex.org/W2112393840"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2132625873","counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-22T12:46:00.618207","created_date":"2016-06-24T00:00:00"}
